Janover Inc Common Stock (JNVR) has had the highest return since January 1, 2025 by a US stock in the Nasdaq Composite (IXIC), returning 1,583.9%.
| ASSET | % RETURN |
|---|---|
Janover Inc Common Stock (JNVR) | 1,583.86% |
Regencell Bioscience (RGC) | 1,105.71% |
Oncology Institute (TOI) | 815.03% |
Sol Gel Technologies (SLGL) | 668.42% |
Dominari (DOMH) | 501.04% |
Protagenic Therapeutics (PTIX) | 492.55% |
Global Interactive Technologies (GITS) | 456.02% |
Yoshiharu Global (YOSH) | 442.73% |
Regulus Therapeutics (RGLS) | 390.63% |
Mobile-health Network Solutions Class A Ordinary Shares (MNDR) | 376.48% |
Cantor Equity Partners, Inc Class A Ordinary Shares (CEP) | 352.36% |
Abits (ABTS) | 338.87% |
CervoMed (CRVO) | 327.08% |
Upexi (UPXI) | 290.83% |
Nutex Health (NUTX) | 257.88% |
Oriental Culture Holding (OCG) | 240.28% |
Junee Limited Ordinary Shares (JUNE) | 217.77% |
ThredUp (TDUP) | 206.94% |
NETCLASS TECHNOLOGY INC Class A Ordinary Shares (NTCL) | 199.66% |
QuantaSing Group Limited American Depositary Shares (QSG) | 181.9% |
Neuronetics (STIM) | 177.58% |
DBV Technologies (DBVT) | 172.04% |
VivoPower International (VVPR) | 168.89% |
TMC the metals (TMC) | 161.4% |
Rapid Micro Biosystems (RPID) | 159.34% |
